Claudin‐2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences

BACKGROUND: Predicting any future metastatic site of early‐stage breast cancer is important as it significantly influences the prognosis of advanced disease. This study aimed at investigating the potential of claudin‐2, over‐expressed in breast cancer liver metastases, as a biomarker for predicting...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Mol Oncol
Hoofdauteurs: Kimbung, Siker, Kovács, Anikó, Bendahl, Pär-Ola, Malmström, Per, Fernö, Mårten, Hatschek, Thomas, Hedenfalk, Ingrid
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2013
Onderwerpen:
Research Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5528500/
https://ncbi.nlm.nih.gov/pubmed/24287398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2013.10.002
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items